Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.15    0.00 (0.00%)
Bid:
1.10
Ask:
1.20
Spread: 0.10 (9.091%)
Market Cap: £9.84m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Results of Open Offer

15 Oct 2025 07:00

RNS Number : 3786D
Tern PLC
15 October 2025
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND FOR INFORMATION PURPOSES ONLY AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, AND DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN, INTO OR FROM THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION, DISTRIBUTION, OFFER OR SALE WOULD BE UNLAWFUL.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO PURCHASE AND/OR SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN TERN PLC OR ANY OTHER ENTITY IN ANY JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION, SHALL FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION WITH ANY INVESTMENT DECISION IN RESPECT OF TERN PLC.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATIONS (EU) NO. 596/2014 WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR").

 

15 October 2025

 

Tern plc

 

("Tern" or the "Company")

 

Results of Open Offer

 

Total voting rights

 

Tern Plc (AIM:TERN), the company focused on value creation from Internet of Things ("IoT") technology businesses, announces the results of its Open Offer to Qualifying Shareholders which was announced on 29 September 2025 and closed for acceptances, in accordance with its terms, on 14 October 2025.

 

The Company announces that valid acceptances have been received from Qualifying Shareholders for a total of 30,227,239 new Ordinary Shares (the "Open Offer Shares") under the Open Offer.

 

As a result, and subject to Admission becoming effective, 30,227,239 Open Offer Shares will be issued in connection with the Open Offer, raising approximately £151,136 (before expenses) for the Company at the Issue Price of 0.50 pence per Open Offer Share.

 

The Open Offer was conducted following the failure to pass the resolution required to issue new Ordinary Shares, disapplying statutory pre-emption rights, at the Company's Annual General Meeting held on 30 June 2025.

 

As announced on 15 September 2025, the repayment date of Tern's loan facility agreement of approximately £150,000 was extended to 5 March 2026. As previously announced, the Company is maintaining strict control over operational costs and looking to make further savings where appropriate, in addition to the significant savings made in 2024 and the current financial year. As announced on 9 October 2025, there is to be a 50 per cent reduction in the salaries of the Company's Directors and Tern's executive managers, effective from 1 November 2025, which is expected to provide a saving of approximately £153,000 on an annualised basis.

 

As at 29 September 2025 when the Open Offer was announced, Tern's unaudited cash balance was approximately £85,000. Following the receipt of the net proceeds of the Open Offer, in the absence of Tern raising further funds or disposing of investments, and on the basis that Tern does not make any investments in its portfolio (including funding its investment in SVV2), the Company would maintain a cash runway which is expected to extend into the first half of Q1 2026. 

 

As stated in the Company's announcement in relation to the launch of the Open Offer on 29 September 2025, in order to seek to cover the Company's funding requirements stated in that announcement, the Company will investigate alternative funding solutions which may include structures that utilise some or all of the Director's remaining authority to allot Ordinary Shares, debt arrangements and asset disposals. These alternatives may be more costly, more dilutive to Shareholders, or less certain in outcome than the Open Offer.

 

Capitalised terms used but not otherwise defined in this announcement bear the meanings ascribed to them in the circular posted to shareholders on 29 September 2025.

 

Director and PDMR participation in the Open Offer

 

The following Directors and persons discharging managerial responsibilities ("PDMRs") of the Company have participated in the Open Offer, as follows:

 

Director

Number of Existing Ordinary Shares

Number of Open Offer Shares subscribed for

Number of Ordinary Shares held on Admission

% of the Enlarged Share Capital on Admission

Iain Ross

1,344,444

268,888

1,613,332

0.24%

 

PDMR

Number of Existing Ordinary Shares

Number of Open Offer Shares subscribed for

Number of Ordinary Shares held on Admission

% of the Enlarged Share Capital on Admission

Albert Sisto

12,328,681

1,000,000*

13,328,681

1.98%

 

* Albert Sisto has a primary residency and tax status in the United States of America. Of his total holdings in the Company, Mr Sisto holds 1,705,348 Existing Ordinary Shares in a UK-based share account which are his only qualifying Existing Ordinary Shares for the purposes of the Open Offer and Mr Sisto's participation for 1,000,000 Open Offer Shares therefore represents more than twice his qualifying basic entitlement of Ordinary Shares.

 

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation (2014/596/EU) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 and as modified by or under the European Union (Withdrawal) Act 2018 or other domestic law, provides further detail.

 

Admission and dealings

 

The Open Offer Shares will, when issued, be credited as fully paid and will rank pari passu in all respects with each other and with the Existing Ordinary Shares, including the right to receive all dividends and other distributions declared, made or paid after the date of Admission. Application has been made to the London Stock Exchange for the Open Offer Shares to be admitted to trading on AIM ("Admission"). Dealings in the Open Offer Shares and Admission are expected to take place on or around 8.00 a.m. on 16 October 2025.

 

Total voting rights

 

In accordance with the Financial Conduct Authority's Disclosure, Guidance and Transparency Rules, the Company confirms that following Admission, the Company's enlarged issued ordinary share capital will comprise 672,713,705 Ordinary Shares. The Company does not hold any shares in Treasury. Therefore, from Admission, the total number of voting rights in the Company will be 672,713,705 and this figure may be used by shareholders in the Company as the denominator for the calculations to determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure Guidance and Transparency Rules.

 

Enquiries:

 

Tern Plc

Jane McCracken (Interim Non-Executive Chair)

via IFC Advisory

 

Allenby Capital Limited

(Nominated Adviser and Broker)

Alex Brearley / Dan Dearden-Williams (Corporate Finance)

Kelly Gardiner (Sales and Corporate Broking)

 

Tel: 0203 328 5656

 

IFC Advisory

(Financial PR and IR)

Tim Metcalfe

Graham Herring

Florence Chandler

 

Tel: 0203 934 6630

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

1. Iain Ross

2. Albert Sisto

 

2

Reason for the notification

 

a)

Position/status

1. Director - Non-Executive Director

2. PDMR - Chief Executive Officer

 

b)

Initial notification/Amendment

Initial Notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tern plc

 

b)

LEI

2138005F87SODHL9CQ36 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 0.02 pence each in the Company

Identification code

GB00BFPMV798

b)

Nature of the transaction

Subscription of new Ordinary Shares pursuant to Open Offer

 

c)

Price(s) and volumes(s)

Price(s)

Volume(s)

 

1. 0.50 pence

2. 0.50 pence

 

1. 268,888

2. 1,000,000

 

d)

Aggregated information

N/A

 

Aggregated volume

N/A

 

Price

N/A

 

e)

Date of the transaction

 

14 October 2025 to be completed on 16 October 2025

 

f)

Place of the transaction

Outside of a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEEANELFSFSFFA
Date   Source Headline
9th Jul 20269:42 amRNSResult of GM
30th Jun 202610:49 amRNSResult of AGM
23rd Jun 20267:00 amRNSResults for the year ended 31 December 2025
8th Jun 20267:00 amRNSNotice of AGM
29th May 20265:00 pmRNSTotal Voting Rights
26th May 20267:00 amRNSInvestment in Talking Medicines CLNs
22nd May 20267:00 amRNSDevice Authority Convertible Loan Notes Investment
19th May 20267:00 amRNSPlacing to raise £222,000
12th May 20267:00 amRNS-RDevice Authority Strategic Partnership
8th May 202612:53 pmRNSResult of GM & Update on Open Offer
8th May 20267:00 amRNSResults of Open Offer
21st Apr 20267:00 amRNSOpen Offer and Notice of General Meeting
31st Mar 20265:00 pmRNSTotal Voting Rights
5th Mar 20267:00 amRNSExtension of loan facility agreement
3rd Mar 20267:00 amRNSResults of Open Offer
13th Feb 20267:00 amRNSOpen Offer at 0.40p to raise up to £384,408
5th Feb 20267:00 amRNS-RTern Notes Automotive Momentum at Device Authority
15th Jan 20267:00 amRNSUpdate regarding SVV2
8th Jan 20267:00 amRNSInvestor Presentations
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
12th Dec 20257:00 amRNSIssue of Talking Medicines Convertible Loan Notes
28th Nov 20257:00 amRNSUpdate regarding capital commitment to SVV2
25th Nov 20257:00 amRNSTalking Medicines CLN Modifications
31st Oct 20253:35 pmRNSTotal Voting Rights
15th Oct 20257:00 amRNSResults of Open Offer
9th Oct 20257:00 amRNSRemuneration Reductions & Distribution Commitment
29th Sep 20257:00 amRNSOpen Offer to raise up to £642,486
15th Sep 20257:00 amRNSExtension of Loan Facility Term
4th Sep 20257:00 amRNSInterim results for the six months to 30 June 2025
1st Sep 20257:00 amRNSAppointment of shareholder relations adviser
31st Jul 20254:34 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults of underwritten Open Offer & TVR
24th Jul 20257:00 amRNSReceipt of Bridging Loan
14th Jul 20257:00 amRNSUnderwritten Open Offer to raise £642,486
30th Jun 202512:07 pmRNSResult of AGM
13th Jun 20257:00 amRNSDirector Share Purchase
11th Jun 20257:00 amRNSDirector Share Purchase
6th Jun 20257:00 amRNSNotice of AGM and Director Retirement
5th Jun 20257:00 amRNSResults for the year ended 31 December 2024
30th May 20255:39 pmRNSTotal Voting Rights
7th May 20257:00 amRNSResults of Underwritten Open Offer
24th Apr 20257:00 amRNSPurple Transform appointment
17th Apr 20257:00 amRNSUnderwritten Open Offer to raise £340,140
11th Mar 20257:00 amRNS-RDevice Authority Microsoft & CyberArk Partnership
11th Mar 20257:00 amRNS-RSure Ventures Update
28th Feb 20255:00 pmRNSTotal Voting Rights
21st Feb 20257:00 amRNSPlacing to raise £221,154
14th Jan 20257:30 amRNS-RProgressive Equity Research Report
10th Jan 20257:00 amRNSInvestor Presentations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.